October 2016 | CrossLife founder & Chief Executive Officer, Dr. HyunDae Cho has been asked to serve on two Special Emphasis Review Panel by the National Institutes of Health (U.S. NIH), Bioanalytical Chemistry, Biophysics, and Assay...
Read more
July 2016 | CrossLife has recently been awarded a Phase 1 Small Business Innovative Research (SBIR) grant from NIH/NIAID for A Rapid Paper Strip Nucleic Acid Test for the Detection of Chikungunya at the Point of Care ...
Read more
July 2016 | CrossLife has recently been awarded a Phase 1 Small Business Innovative Research (SBIR) grant from NIH/NIAID for Point-of-Care Rapid RNA test for HIV ...
Read more
June 2016 | We have successfully finished the NIH I-Corps entrepreneur immersion program (March 2016- May 2016). We have assembled an I-Corp team composed of an experienced industry expert who is a Key Opinion Leader in the diagnostics industry...
Read more
May 2016 | CrossLife has recently been awarded a Phase 1 Small Business Innovative Research (SBIR) grant from NIH/NCATS for Point-of-Care Rapid RNA Diagnosis of Influenza Virus ...
Read more
March 2016 | NIH I-Corps | CrossLife has been selected for the highly competitive NIH I-Corps entrepreneur immersion training program. The goal of the program is to identify customers and markets for our point-of-care dengue diagnostic, and to...
Read more
We provide an enzyme-free, PCR-less, instrumentation-free, low-cost, disposable, rapid and sensitive POC dengue diagnostics directly from whole blood samples.
Read more